Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Daniel Chargelegue"'
Publikováno v:
Journal of Biological Chemistry. 279:22198-22203
Guy's 13 is a mouse monoclonal antibody that specifically recognizes the major cell-surface adhesion protein SA I/II of Streptococcus mutans, one of the major causative agents of dental caries. Passive immunization with Guy's 13 prevents bacterial co
Autor:
Patricia Obregon, Pascal M. W. Drake, Julian K.-C. Ma, Daniel Chargelegue, Nicholas D. Vine, Craig J. van Dolleweerd
Publikováno v:
Plant Molecular Biology. 52:233-241
The secretion of a functional, full-length monoclonal antibody complex from transgenic Nicotiana tabacum roots has been demonstrated. Initially, seeds were germinated on nitrocellulose membranes and antibody secretion detected from the developing roo
Autor:
Julian K.-C. Ma, Craig J. van Dolleweerd, Nicholas D. Vine, Daniel Chargelegue, Pascal M. W. Drake, Patricia Obregon
Publikováno v:
The FASEB Journal. 16:1855-1860
The feasibility of using antibody expressing transgenic plants either to neutralize bioactive molecules in the rhizosphere, or to accumulate and concentrate the molecules in leaves has been demonstrated in a model system consisting of hydroponic Nico
Publikováno v:
Transgenic Research. 9:187-194
Previous studies have shown that the production of recombinant antibodies in plants is highly efficient and presents numerous therapeutic applications. It is, however, known that plant glycoproteins display different glycosylation patterns to those e
Autor:
James Nuttall, Daniel Chargelegue, Patricia Obregon, Lorenzo Frigerio, Julian K.-C. Ma, Alessandra Prada, Pascal M. W. Drake
Publikováno v:
Plant biotechnology journal. 4(2)
We describe the engineering of a human immunodeficiency virus-1 (HIV-1) p24-immunoglobulin A (IgA) antigen-antibody fusion molecule for therapeutic purposes and its enhancing effect on fused antigen expression in tobacco plants. Although many recombi
Autor:
Patricia Obregon, Alessandra Prada, Julian K.-C. Ma, Daniel Chargelegue, Neil F. Fairweather, Pascal M. W. Drake
Vaccine development has been hampered by difficulties in developing new and safe adjuvants, so alternative technologies that offer new avenues forward are urgently needed. The goal of this study was to express a monoclonal recombinant immune complex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35e9562bdfe21841926376c7b3488635
https://europepmc.org/articles/PMC1231086/
https://europepmc.org/articles/PMC1231086/
Publikováno v:
Molecular Farming: Plant-Made Pharmaceuticals and Technical Proteins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8caf97f5650d11cd31ecd85fc2096da4
https://doi.org/10.1002/3527603638.ch10
https://doi.org/10.1002/3527603638.ch10
Publikováno v:
Vaccine. 23(15)
The use of transgenic plants for the production of recombinant proteins is not a universal solution for all proteins. The choice of this expression system depends very much on the type of protein and its applications. Many proteins will best be made
Publikováno v:
Infection and immunity. 71(2)
Guy's 13 is a mouse monoclonal antibody which recognizes streptococcal antigen I/II (SA I/II), a major cell surface glycoprotein of Streptococcus mutans . In a number of clinical trials, this antibody has been shown to prevent colonization in the hum
Autor:
Patricia Obregon, Julian K.-C. Ma, Daniel Chargelegue, Alessandra Prada, Pascal M. W. Drake, Lorenzo Frigerio
Publikováno v:
Plant Biotechnology 2002 and Beyond ISBN: 9789048162208
There is increasing interest in transgenic plant technology for the production of a wide range of recombinant proteins for pharmaceutical and industrial uses. There are many potential benefits in using plants as bioreactors for the production of such
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb4912637e29ad009e440ec147be5204
https://doi.org/10.1007/978-94-017-2679-5_75
https://doi.org/10.1007/978-94-017-2679-5_75